Articles

What’s changing in cannabis law: our editors’ articles, and announcements straight from regulators, courts, governments and companies.

Search articles

2 articles

SortNewestOldest

• #health canada ×
• Clear all

Press release · PR Newswire

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression

Optimi’s 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression. The export marks Optimi’s third commercial shipment since launching the 5mg psilocybin capsules in September 2025.

30 Jun 2026

• Psychedelics
• Medical cannabis
• Import and export
• Australia
• Canada

Press release · GlobeNewswire

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

Two naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled studies

20 Jun 2026

• Psychedelics
• Research
• Medical cannabis
• Canada
• Australia
• British Columbia, Canada